ConCallIQ
Go Pro
DABUR Diversified 07 Aug 2024

Dabur India Limited — Q1 FY25

Dabur India reported a steady Q1 FY25 with consolidated revenue growing 7% YoY in INR terms, driven by 5.2% volume growth in the domestic business.

bullish medium
Compare with...
Revenue ₹3,349 Cr +7%
EBITDA +8.3%
PAT ₹494 Cr +7.8%
EBITDA Margin +30bps
Duration
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Dabur India reported a steady Q1 FY25 with consolidated revenue growing 7% YoY in INR terms, driven by 5.2% volume growth in the domestic business. International business surged 18.4% in constant currency, though currency devaluation impacted INR growth. Gross margins expanded 120 bps YoY, aided by moderation in input costs and cost-saving initiatives. Operating profit grew 8.3%, with margin expansion of 30 bps. The company gained market share in 95% of its portfolio, with strong performance in oral care (11.4% growth), healthcare (7%), and HPC (8.1%). Rural recovery is underway, with sequential volume improvement over the past three quarters. Management remains optimistic about demand pickup driven by normal monsoons and rural-focused government spending. Key risk: intense competition in hair oils and pricing pressure in the juices/nectars segment due to cola price wars.

Promises0 met · 4 missedRisks4 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 4 promises

Promise Tracker

0 delivered, 0 close, 4 missed.

View Promises →
!Risks 4 risks

Risk Intelligence

Intense competition in hair oils

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Volume Growth (India Business) 5.2%
+1.2pp YoY

Sequential improvement from 3% to 4% to 5.2% over last three quarters, indicating rural recovery.

Market Share Gains 95%
N/A

Gained market share in 95% of portfolio categories, driven by distribution and brand investments.

International Business CC Growth 18.4%
+18.4pp YoY

Strong growth led by Turkey (19%), Egypt (64%), MENA (13%), SSA (21%), Bangladesh (25%).

Quick Commerce Growth 70%
+70pp YoY

Quick commerce now 30-35% of e-commerce, with margins better than general e-commerce.

What Changed vs Last Quarter

Comparing Q1 FY25 vs Q4 FY24
4 new guidance4 dropped3 new risk3 risk resolved
NEW
Volume growth expected to improve sequentially

Management expects volume growth to continue picking up in subsequent quarters, driven by rural recovery and government spending.

NEW
Gross margin improvement of 120 bps partly reinvested

Around 80% of gross margin gains will be reinvested into advertising and promotion, with balance flowing to operating margin.

NEW
Home care target of INR 1,000 crore

Management aims to grow home care (Odomos, Odonil) from ~INR 800 crore to INR 1,000 crore by expanding total addressable market.

NEW
Legal costs for Namaste case to reduce

Legal costs expected to be ~INR 80 crore for FY25 vs INR 100 crore last year, with potential insurance recovery of 50%.

DROPPED
Mid-to-high single-digit volume growth in FY25

Management targets volume growth of 5-7.5% for FY25, driven by rural recovery and distribution expansion.

DROPPED
Operating margin target of ~20% in FY25

On a like-to-like basis (excluding legal costs), operating margin is expected to be around 20%, with gradual improvement.

DROPPED
Legal costs of INR 80-90 crore in FY25

The US legal case will incur similar costs as FY24, around INR 80-90 crore, spread quarterly.

DROPPED
Double-digit growth target for beverages in FY25

Beverage business targets double-digit growth in FY25, assuming normal summer weather.

NEW RISK
Intense competition in hair oils

Bajaj and Emami have become aggressive in coconut oil, leading to margin squeeze and price corrections. Dabur's Sarson Amla underperformed due to softening mustard oil prices.

NEW RISK
Pricing pressure in juices/nectars from cola wars

Price premium of nectars vs colas widened from 2.2x to 3.2x due to aggressive pricing by new cola entrants, impacting nectar growth despite market share gains.

NEW RISK
South India remains under pressure

While rural recovery is visible in UP, Bihar, and Central India, South India continues to face demand weakness, which could weigh on overall growth.

RISK GONE
Weather volatility impacting seasonal portfolio

Unseasonal rains and delayed winters hurt health supplements and beverages; similar weather risks persist.

RISK GONE
US legal case costs and outcome uncertainty

Legal costs of INR 80-90 crore annually continue; case outcome remains uncertain despite management confidence.

RISK GONE
Competitive pressure from unorganized players

Analyst raised concern about unorganized players gaining share in rural recovery; management acknowledged but downplayed risk.

🤫 Topics management stopped discussing

Direct reach target of 1.5 million outlets by fiscal year-end

Mentioned in Q2 FY24, Q3 FY24

Direct distribution reach to increase from 1.42 million to 1.5 million outlets by end of FY24.

Foods portfolio to exit year at INR 500 crore run rate

Mentioned in Q1 FY24, Q2 FY24

Despite high spice inflation, Dabur remains committed to exiting the fiscal year with a run rate of INR 500 crore from its foods portfolio.

International business to sustain high double-digit constant currency growth in H2

Mentioned in Q1 FY24, Q2 FY24

Management expects international business to continue high double-digit constant currency growth in second half, barring escalation of Middle East conflict.

US legal case costs and outcome uncertainty

Mentioned in Q3 FY24, Q4 FY24

Legal costs of INR 80-90 crore annually continue; case outcome remains uncertain despite management confidence.

Fast read

Guidance and risk preview

Top guidance Volume growth expected to improve sequentially

Management expects volume growth to continue picking up in subsequent quarters, driven by rural recovery and government spending.

Top risk Intense competition in hair oils

Bajaj and Emami have become aggressive in coconut oil, leading to margin squeeze and price corrections.

View Risks →